XLRN insider filings

ACCELERON PHARMA INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-11-22. Screen XLRN transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for XLRN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ACCELERON PHARMA INC

FiledFormInsiderReported transactionsSource
2021-11-224Zakrzewski Joseph S — DirectorCode (U): 34,499 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · +2 moreEDGAR
2021-11-224Malik Kemal — DirectorCode (U): 1,622 · Disposition to issuer (D): 17,956 (derivative) · Disposition to issuer (D): 3,222 (derivative)EDGAR
2021-11-224Hite Christopher — DirectorCode (U): 930 · Disposition to issuer (D): 10,267 (derivative) · Disposition to issuer (D): 1,848 (derivative)EDGAR
2021-11-224Smith Karen L. — DirectorCode (U): 1,622 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 1,875 (derivative) · Disposition to issuer (D): 3,750 (derivative) · Disposition to issuer (D): 4,085 (derivative) · Disposition to issuer (D): 3,222 (derivative)EDGAR
2021-11-224MCCOURT Thomas A — DirectorCode (U): 6,044 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 8,185 (derivative) · Disposition to issuer (D): 3,222 (derivative)EDGAR
2021-11-224Kearney Terrence C — DirectorCode (U): 6,749 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,665 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 8,185 (derivative) · Disposition to issuer (D): 3,222 (derivative)EDGAR
2021-11-224Hamill Laura — DirectorCode (U): 474 · Disposition to issuer (D): 9,339 (derivative) · Disposition to issuer (D): 941 (derivative)EDGAR
2021-11-224Nader Francois — DirectorCode (U): 6,749 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 576 (derivative) · +4 moreEDGAR
2021-11-224Veness Adam M — SVP, General Counsel and Sec.Code (U): 23,423 · Disposition to issuer (D): 6,700 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 8,500 (derivative) · Disposition to issuer (D): 24,334 (derivative) · Disposition to issuer (D): 18,806 (derivative)EDGAR
2021-11-224KANGO SUJAY — EVP, Chief Commercial OfficerCode (U): 18,509 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,500 (derivative) · Disposition to issuer (D): 24,334 (derivative) · Disposition to issuer (D): 20,896 (derivative)EDGAR
2021-11-224Backstrom Jay T. — EVP, Research and DevelopmentCode (U): 21,233 · Disposition to issuer (D): 96,963 (derivative) · Disposition to issuer (D): 20,896 (derivative)EDGAR
2021-11-224Dable Habib J — CEO and President, DirectorCode (U): 98,450 · Disposition to issuer (D): 250,000 (derivative) · Disposition to issuer (D): 108,800 (derivative) · Disposition to issuer (D): 106,400 (derivative) · Disposition to issuer (D): 84,720 (derivative) · Disposition to issuer (D): 64,361 (derivative)EDGAR
2021-11-224MCLAUGHLIN KEVIN F — SVP, CFO and TreasurerCode (U): 10,681 · Disposition to issuer (D): 2,663 (derivative) · Disposition to issuer (D): 11,262 (derivative) · Disposition to issuer (D): 20,500 (derivative) · Disposition to issuer (D): 24,334 (derivative) · Disposition to issuer (D): 18,806 (derivative)EDGAR
2021-11-124Veness Adam M — SVP, General Counsel and Sec.Option exercise (M): 4,500 @ $29.37 · Option exercise (M): 4,500 (derivative) @ $0EDGAR
2021-09-274KANGO SUJAY — EVP, Chief Commercial OfficerOption exercise (M): 5,000 @ $40.61 · Sale (S): 5,000 @ $175 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2021-09-244MCLAUGHLIN KEVIN F — SVP, CFO and TreasurerOption exercise (M): 2,500 @ $30.17 · Option exercise (M): 9,800 @ $40.61 · Option exercise (M): 7,330 @ $41.64 · Sale (S): 18,647 @ $160.26 · Sale (S): 983 @ $161.26 · Option exercise (M): 5,200 @ $40.61 · +7 moreEDGAR
2021-09-224Veness Adam M — SVP, General Counsel and Sec.Option exercise (M): 5,200 @ $30.17 · Option exercise (M): 1,450 @ $41.20 · Sale (S): 6,650 @ $150.05 · Option exercise (M): 5,200 (derivative) @ $0 · Option exercise (M): 1,450 (derivative) @ $0EDGAR
2021-09-224KANGO SUJAY — EVP, Chief Commercial OfficerOption exercise (M): 5,000 @ $40.61 · Sale (S): 5,000 @ $150.03 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2021-09-094Veness Adam M — SVP, General Counsel and Sec.Tax withholding (F): 587 @ $129.36 · Sale (S): 6 @ $130 · Sale (S): 1,407 @ $130EDGAR
2021-07-024Dable Habib J — CEO and President, DirectorOption exercise (M): 57,814 @ $35.04 · Sale (S): 11,845 @ $125.15 · Sale (S): 9,194 @ $125.81 · Sale (S): 23,160 @ $126.85 · Sale (S): 4,560 @ $127.89 · Sale (S): 9,055 @ $128.82 · +6 moreEDGAR
2021-06-084Veness Adam M — SVP, General Counsel and Sec.Tax withholding (F): 108 @ $126.69EDGAR
2021-06-084KANGO SUJAY — EVP, Chief Commercial OfficerTax withholding (F): 887 @ $130.87EDGAR
2021-04-214MCCOURT Thomas A — DirectorOption exercise (M): 7,500 @ $40.61 · Sale (S): 2,127 @ $118.39 · Sale (S): 4,030 @ $119.36 · Sale (S): 1,143 @ $120.16 · Sale (S): 200 @ $121.23 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2021-04-054Zakrzewski Joseph S — DirectorOption exercise (M): 10,000 @ $24.11 · Sale (S): 6,748 @ $140.31 · Sale (S): 2,152 @ $141.28 · Sale (S): 1,100 @ $142.27 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-04-054Smith Karen L. — DirectorOption exercise (M): 5,000 @ $35.34 · Option exercise (M): 1,875 @ $41.64 · Option exercise (M): 2,050 @ $52.99 · Sale (S): 11,223 @ $140.13 · Sale (S): 641 @ $141.15 · Option exercise (M): 5,000 (derivative) @ $0 · +2 moreEDGAR
2021-04-024Zakrzewski Joseph S — DirectorOption exercise (M): 10,000 @ $24.11 · Sale (S): 104 @ $132.61 · Sale (S): 6,596 @ $134.27 · Sale (S): 1,700 @ $135.22 · Sale (S): 1,600 @ $135.67 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-04-024Smith Karen L. — DirectorOption exercise (M): 5,000 @ $35.34 · Option exercise (M): 1,875 @ $41.64 · Option exercise (M): 2,050 @ $52.99 · Sale (S): 1,201 @ $134.54 · Sale (S): 2,987 @ $136.22 · Sale (S): 3,796 @ $136.92 · +4 moreEDGAR
2021-03-044KANGO SUJAY — EVP, Chief Commercial OfficerOption exercise (M): 5,000 @ $40.61 · Sale (S): 2,699 @ $135.48 · Sale (S): 1,501 @ $136.24 · Sale (S): 600 @ $137.12 · Sale (S): 200 @ $138.15 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2021-02-024Veness Adam M — SVP, General Counsel and Sec.Grant/award (A): 4,868 @ $0 · Grant/award (A): 18,806 (derivative) @ $0EDGAR
2021-02-024KANGO SUJAY — EVP, Chief Commercial OfficerGrant/award (A): 5,409 @ $0 · Grant/award (A): 20,896 (derivative) @ $0EDGAR
2021-02-024Backstrom Jay T. — EVP, Research and DevelopmentGrant/award (A): 5,409 @ $0 · Grant/award (A): 20,896 (derivative) @ $0EDGAR
2021-02-024Dable Habib J — CEO and President, DirectorGrant/award (A): 16,662 @ $0 · Grant/award (A): 64,361 (derivative) @ $0EDGAR
2021-02-024Zakrzewski Joseph S — DirectorGrant/award (A): 1,622 @ $0 · Grant/award (A): 3,222 (derivative) @ $0EDGAR
2021-02-024Smith Karen L. — DirectorGrant/award (A): 1,622 @ $0 · Grant/award (A): 3,222 (derivative) @ $0EDGAR
2021-02-024MCCOURT Thomas A — DirectorGrant/award (A): 1,622 @ $0 · Grant/award (A): 3,222 (derivative) @ $0EDGAR
2021-02-024Malik Kemal — DirectorGrant/award (A): 1,622 @ $0 · Grant/award (A): 3,222 (derivative) @ $0EDGAR
2021-02-024Kearney Terrence C — DirectorGrant/award (A): 1,622 @ $0 · Grant/award (A): 3,222 (derivative) @ $0EDGAR
2021-02-024Hite Christopher — DirectorGrant/award (A): 930 @ $0 · Grant/award (A): 1,848 (derivative) @ $0EDGAR
2021-02-024Hamill Laura — DirectorGrant/award (A): 474 @ $0 · Grant/award (A): 941 (derivative) @ $0EDGAR
2021-02-024Nader Francois — DirectorGrant/award (A): 1,622 @ $0 · Grant/award (A): 3,222 (derivative) @ $0EDGAR
2021-02-024/AKANGO SUJAY — EVP, Chief Commercial OfficerOption exercise (M): 10,000 @ $40.61 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-02-024MCLAUGHLIN KEVIN F — SVP, CFO and TreasurerGrant/award (A): 4,868 @ $0 · Grant/award (A): 18,806 (derivative) @ $0EDGAR
2021-01-064Veness Adam M — SVP, General Counsel and Sec.Tax withholding (F): 942 @ $124.31 · Sale (S): 1,900 @ $122.46 · Sale (S): 56 @ $122.93 · Sale (S): 100 @ $124.30EDGAR
2021-01-064KANGO SUJAY — EVP, Chief Commercial OfficerTax withholding (F): 1,357 @ $124.31 · Sale (S): 1,947 @ $123.90 · Sale (S): 3,429 @ $125.17 · Sale (S): 4,624 @ $126.15EDGAR
2021-01-064Backstrom Jay T. — EVP, Research and DevelopmentTax withholding (F): 1,735 @ $124.31EDGAR
2021-01-064Dable Habib J — CEO and President, DirectorTax withholding (F): 3,278 @ $124.31 · Sale (S): 2,500 @ $120.52 · Sale (S): 900 @ $121.55 · Sale (S): 764 @ $122.46 · Sale (S): 94 @ $122.55EDGAR
2021-01-064MCLAUGHLIN KEVIN F — SVP, CFO and TreasurerTax withholding (F): 624 @ $124.31 · Sale (S): 800 @ $123.54 · Sale (S): 713 @ $124.28 · Sale (S): 200 @ $125.49 · Sale (S): 600 @ $123.49 · Sale (S): 667 @ $124.47 · +5 moreEDGAR
2020-12-154MCLAUGHLIN KEVIN F — SVP, CFO and TreasurerOption exercise (M): 7,252 @ $41.20 · Option exercise (M): 7,700 @ $27.97 · Option exercise (M): 24,986 @ $30.17 · Option exercise (M): 2,590 @ $40.61 · Sale (S): 42,528 @ $130.14 · Option exercise (M): 7,252 (derivative) @ $0 · +3 moreEDGAR
2020-12-114MCLAUGHLIN KEVIN F — SVP, CFO and TreasurerOption exercise (M): 548 @ $41.20 · Option exercise (M): 400 @ $27.97 · Option exercise (M): 1,051 @ $30.17 · Option exercise (M): 1,873 @ $40.61 · Sale (S): 3,872 @ $125.03 · Option exercise (M): 100 @ $41.20 · +15 moreEDGAR
2020-10-134Kearney Terrence C — DirectorOption exercise (M): 20,000 @ $28.37 · Option exercise (M): 10,000 @ $27.97 · Option exercise (M): 7,500 @ $30.17 · Sale (S): 2,200 @ $117.82 · Sale (S): 18,177 @ $119.11 · Sale (S): 16,210 @ $119.78 · +4 moreEDGAR

Recent 8-K events — ACCELERON PHARMA INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-11-228-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2021-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-10-278-K2.02 — Results of Operations and Financial ConditionEDGAR
2021-09-308-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-07-288-K2.02 — Results of Operations and Financial ConditionEDGAR
2021-06-228-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2021-06-218-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2021-06-178-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-05-198-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=XLRN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs